Compare SHOO & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHOO | BHC |
|---|---|---|
| Founded | 1990 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.5B |
| IPO Year | 1996 | 1996 |
| Metric | SHOO | BHC |
|---|---|---|
| Price | $32.75 | $5.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | ★ $42.43 | $8.33 |
| AVG Volume (30 Days) | 1.2M | ★ 2.1M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.53% | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ 0.63 | 0.42 |
| Revenue | $2,534,109,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $12.39 | $4.48 |
| Revenue Next Year | $5.90 | N/A |
| P/E Ratio | $52.66 | ★ $12.19 |
| Revenue Growth | ★ 11.00 | N/A |
| 52 Week Low | $19.05 | $4.28 |
| 52 Week High | $46.88 | $8.69 |
| Indicator | SHOO | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 41.04 | 35.56 |
| Support Level | $31.85 | $4.93 |
| Resistance Level | $35.50 | $7.22 |
| Average True Range (ATR) | 1.27 | 0.17 |
| MACD | 0.28 | 0.02 |
| Stochastic Oscillator | 37.48 | 14.42 |
Steven Madden Ltd and its subsidiaries design, source, and market branded and private label footwear, accessories, and apparel. Its offerings include contemporary styles and core products, known for design creativity, trend-right offerings, high quality, and accessible price points. It operates through four segments: Wholesale Footwear, which generates maximum revenue and sells footwear globally; Wholesale Accessories/Apparel, which sells handbags and apparel through wholesale channels; Direct-to-Consumer, which sells footwear, handbags, apparel, and accessories through stores, outlets, e-commerce, and concessions; and Licensing, which licenses Steve Madden, Betsey Johnson, and Kurt Geiger trademarks, with the Company generating the majority of its revenue from the USA.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.